{"id":"https://openalex.org/W2014976890","doi":"https://doi.org/10.2174/1568026054201640","title":"Global Safety of Coxibs and NSAIDs","display_name":"Global Safety of Coxibs and NSAIDs","publication_year":2005,"publication_date":"2005-06-01","ids":{"openalex":"https://openalex.org/W2014976890","doi":"https://doi.org/10.2174/1568026054201640","mag":"2014976890","pmid":"https://pubmed.ncbi.nlm.nih.gov/15974941"},"language":"en","primary_location":{"id":"doi:10.2174/1568026054201640","doi":"https://doi.org/10.2174/1568026054201640","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1568026054201640","pdf_url":null,"source":{"id":"https://openalex.org/S107732428","display_name":"Current Topics in Medicinal Chemistry","issn_l":"1568-0266","issn":["1568-0266","1873-4294"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Topics in Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012063479","display_name":"Kevin M. Pham","orcid":"https://orcid.org/0000-0003-1181-9997","observed_orcids":["https://orcid.org/0000-0003-1181-9997"]},"institutions":[{"id":"https://openalex.org/I177607063","display_name":"The Lundquist Institute","ror":"https://ror.org/025j2nd68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I177607063"]},{"id":"https://openalex.org/I4210165985","display_name":"Harbor\u2013UCLA Medical Center","ror":"https://ror.org/05h4zj272","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1328359107","https://openalex.org/I4210165985"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Pham","raw_affiliation_strings":["Department of Nephrology & Hypertension, Harbor-UCLA Medical Center, Los Angeles Biomedical Research Institute (LABioMed), 1124 West Carson St, Torrance, CA 90502, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology & Hypertension, Harbor-UCLA Medical Center, Los Angeles Biomedical Research Institute (LABioMed), 1124 West Carson St, Torrance, CA 90502, USA","institution_ids":["https://openalex.org/I177607063","https://openalex.org/I4210165985"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089452946","display_name":"Raimund R. Hirschberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Hirschberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.3394,"has_fulltext":false,"cited_by_count":33,"citation_normalized_percentile":{"value":0.87252523,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"5","issue":"5","first_page":"465","last_page":"473"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.9020000100135803},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.890999972820282},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.972000002861023},{"id":"https://openalex.org/keywords/gastrointestinal-complications","display_name":"gastrointestinal complications","score":0.7400000095367432},{"id":"https://openalex.org/keywords/upper-gastrointestinal-bleeding","display_name":"upper gastrointestinal bleeding","score":0.9210000038146973},{"id":"https://openalex.org/keywords/cardiovascular-safety","display_name":"cardiovascular safety","score":0.6840000152587891},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.9990000128746033},{"id":"https://openalex.org/keywords/renal-safety","display_name":"renal safety","score":0.7580000162124634},{"id":"https://openalex.org/keywords/acute-kidney-injury","display_name":"acute kidney injury","score":0.9539999961853027},{"id":"https://openalex.org/keywords/low-dose-aspirin","display_name":"low-dose aspirin","score":0.8539999723434448},{"id":"https://openalex.org/keywords/naproxen","display_name":"naproxen","score":0.9639999866485596},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.7870000004768372},{"id":"https://openalex.org/keywords/osteoarthritis","display_name":"osteoarthritis","score":0.9169999957084656},{"id":"https://openalex.org/keywords/pain-management","display_name":"pain management","score":0.531000018119812}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9335996508598328},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.7056578397750854},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.6915205121040344},{"id":"https://openalex.org/C2778115740","wikidata":"https://www.wikidata.org/wiki/Q1215575","display_name":"Naproxen","level":3,"score":0.6611549854278564},{"id":"https://openalex.org/C2776164576","wikidata":"https://www.wikidata.org/wiki/Q62736","display_name":"Osteoarthritis","level":3,"score":0.6484745740890503},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.5277476906776428},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4863770306110382},{"id":"https://openalex.org/C2780820201","wikidata":"https://www.wikidata.org/wiki/Q173235","display_name":"Analgesic","level":2,"score":0.44618362188339233},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.42071953415870667},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3849096894264221},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3171674311161041},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005767","descriptor_name":"Gastrointestinal Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007674","descriptor_name":"Kidney Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D012306","descriptor_name":"Risk","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2174/1568026054201640","doi":"https://doi.org/10.2174/1568026054201640","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1568026054201640","pdf_url":null,"source":{"id":"https://openalex.org/S107732428","display_name":"Current Topics in Medicinal Chemistry","issn_l":"1568-0266","issn":["1568-0266","1873-4294"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Topics in Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:15974941","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15974941","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current topics in medicinal chemistry","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.8700000047683716,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2169698788","https://openalex.org/W1491811518","https://openalex.org/W2599217962","https://openalex.org/W4246361533","https://openalex.org/W1575211640","https://openalex.org/W1999401349","https://openalex.org/W2298123402","https://openalex.org/W2148786141","https://openalex.org/W2006228380","https://openalex.org/W78596795"],"abstract_inverted_index":{"Non-steroidal":[0],"anti-inflammatory":[1],"drugs":[2],"(NSAIDs)":[3],"and":[4,16,24,51,58,74,105,158,163],"selective":[5],"cyclooxygenase-2":[6],"inhibitors":[7],"(Coxibs)":[8],"are":[9,31,90,142],"commonly":[10],"used":[11],"for":[12,79],"minor":[13],"pain":[14],"treatment":[15],"chronically":[17],"in":[18,132,167],"the":[19,84],"management":[20],"of":[21,28,36,63,87,125],"rheumatoid":[22],"arthritis":[23],"osteoarthritis.":[25],"Three":[26],"areas":[27],"safety":[29,47,53,96],"concerns":[30],"shared":[32],"by":[33],"both":[34],"groups":[35,86],"drugs:":[37],"Gastrointestinal":[38],"complications":[39,65],"(upper":[40],"gastrointestinal":[41,95],"bleeding,":[42],"perforations":[43],"or":[44,72],"obstruction),":[45],"cardiovascular":[46,126],"(mainly":[48],"myocardial":[49,129],"infarction)":[50],"renal":[52,55,64],"(acute":[54],"failure,":[56],"hypertension":[57],"electrolyte":[59],"abnormalities).":[60],"The":[61],"incidence":[62,124],"may":[66,106,118],"be":[67,107,119,153],"increased":[68],"two-fold":[69],"with":[70,93,110,121],"NSAIDs":[71,136],"coxibs,":[73],"there":[75],"is":[76,103],"no":[77],"evidence":[78],"a":[80,122],"major":[81],"difference":[82],"between":[83],"two":[85],"drugs.":[88],"Coxibs":[89],"clearly":[91],"associated":[92,120],"improved":[94],"compared":[97],"to":[98,134,155],"NSAIDs,":[99],"but":[100],"this":[101],"benefit":[102],"reduced":[104],"lost":[108],"completely":[109],"concurrent":[111],"low-dose":[112],"aspirin":[113],"use.":[114],"In":[115],"contrast,":[116],"coxibs":[117,141],"greater":[123],"complications,":[127],"mainly":[128],"infarction,":[130],"especially":[131],"comparison":[133],"certain":[135],"such":[137],"as":[138],"naproxen.":[139],"Thus,":[140],"not":[143],"generally":[144],"safer":[145],"than":[146],"NSAIDs.":[147],"Rather,":[148],"their":[149,159,168],"long-term":[150],"use":[151],"should":[152],"customized":[154],"individual":[156],"patients":[157],"intrinsic":[160],"baseline":[161],"risks":[162],"other":[164],"medications":[165],"required":[166],"management.":[169]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}